A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study

The American Journal of Gastroenterology - Tập 112 Số 1 - Trang 172-183 - 2017
Sukhwinder Kaur1,2, Lynette M. Smith3,2, Asish Patel1,2, Melanie Menning1,2, Duncan C. Watley1,2, Saad Saeed Malik1,2, Shiv Ram Krishn1,2, Kavita Mallya1,2, Abhijit Aithal1,2, Aaron R. Sasson4,2, Sonny L. Johansson5, Maneesh Jain1,2, Shailender Singh4,2, Sushovan Guha6,2, Chandrakanth Are4,2, Massimo Raimondo7,2, Michael A. Hollingsworth8,2, Randall E. Brand9,10,2,11, Surinder K. Batra1,12,9,10,2
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA
2Specific author contributions: Sukhwinder Kaur, Melanie Menning, Duncan C. Watley, Abhijit Aithal, Saad S. Malik, Asish Patel, Shiv Ram Krishn, Kavita Mallya were involved in study design, performing biomarker assays, assay interpretation and writing the manuscript. Lynette M. Smith involved in statistical analysis of the data. Aaron Sasson, Sushovan Guha, Maneesh Jain, Shailender Singh, Chandrakantha Are, Massimo Raimondo, Michael A. Hollingsworth and Randall Brand were involved in collection of samples for the study, assay interpretation and writing the manuscript. Surinder K. Batra was involved in study design, interpretation of assays and the writing of the manuscript. Surinder K. Batra and Randall E. Brand are guarantors for the article.
3Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA
4Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska USA
5Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska USA
6Division of Gastroenterology, Hepatology, and Nutrition, The University of Texas Medical School and Health Science Center at Houston, Houston, Texas, USA
7Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA
8Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA
9Guarantor of the article: Surinder K. Batra, PhD and Randall E. Brand, MD.
10Randall E Brand, MD, and Surinder K. Batra, PhD, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA and Department of Biochemistry and Molecular Biology, Buffett Cancer Center, Omaha, Nebraska, USA. E-mail: [email protected] or [email protected]
11University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania USA
12Fred and Pamela Buffett Cancer Center, Omaha, Nebraska, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Rahib, 2014, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States., Cancer Res, 74, 2913, 10.1158/0008-5472.CAN-14-0155

Kaur, 2013, Mucins in pancreatic cancer and its microenvironment., Nat Rev Gastroenterol Hepatol, 10, 607, 10.1038/nrgastro.2013.120

Brand, 2011, Serum biomarker panels for the detection of pancreatic cancer., Clin Cancer Res, 17, 805, 10.1158/1078-0432.CCR-10-0248

Kaur, 2012, Early diagnosis of pancreatic cancer: challenges and new developments., Biomark Med, 6, 597, 10.2217/bmm.12.69

Koopmann, 2006, Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9., Clin Cancer Res, 12, 442, 10.1158/1078-0432.CCR-05-0564

Locker, 2006, ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer., J Clin Oncol, 24, 5313, 10.1200/JCO.2006.08.2644

Goonetilleke, 2007, Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis., Pancreas, 34, 318, 10.1097/MPA.0b013e31802ee9c7

Duffy, 2010, Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report., Ann Oncol, 21, 441, 10.1093/annonc/mdp332

Brody, 2011, The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer., Adv Surg, 45, 301, 10.1016/j.yasu.2011.04.002

Ghaneh, 2008, Biology and management of pancreatic cancer., Postgrad Med J, 84, 478, 10.1136/gut.2006.103333

Goggins, 2005, Molecular markers of early pancreatic cancer., J Clin Oncol, 23, 4524, 10.1200/JCO.2005.19.711

Iacobuzio-Donahue, 2003, Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies., Cancer Res, 63, 8614

Altman, 2012, Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration., BMC Med, 10, 51, 10.1186/1741-7015-10-51

Kaur, 2013, Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas., Pancreas, 42, 494, 10.1097/MPA.0b013e31826a8597

Del Villano, 1983, Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9., Clin Chem, 29, 549, 10.1093/clinchem/29.3.549

Wongkham, 2003, Serum MUC5AC mucin as a potential marker for cholangiocarcinoma., Cancer Lett, 195, 93, 10.1016/S0304-3835(02)00691-2

Albert, 1988, Elevated serum levels of tumor marker CA19-9 in acute cholangitis., Dig Dis Sci, 33, 1223, 10.1007/BF01536670

Dumitra, 2013, Pancreatic cancer and predictors of survival: comparing the CA 19-9bilirubin ratio with the McGill Brisbane Symptom Score., HPB (Oxford), 15, 1002, 10.1111/hpb.12085

Ballehaninna, 2012, The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal., J Gastrointest Oncol, 3, 105

Gold, 2006, New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis., J Clin Oncol, 24, 252, 10.1200/JCO.2005.02.8282

Gold, 2013, PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma., Cancer, 119, 522, 10.1002/cncr.27762

Gold, 2013, Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin., Mol Cancer, 12, 143, 10.1186/1476-4598-12-143

Bunger, 2011, Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview., J Cancer Res Clin Oncol, 137, 375, 10.1007/s00432-010-0965-x

Thông tin
Thông tin xuất bản

The American Journal of Gastroenterology

Tập 112 Số 1

172-183

Thông tin tác giả